Results 211 to 220 of about 11,154 (267)

Retracted Publications in the Drug Literature

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
Recent studies have suggested an increase in the number of retracted scientific publications. It is unclear how broadly the issue of misleading and fraudulent publications pertains to retractions of drug therapy studies. Therefore, we sought to determine the trends and factors associated with retracted publications in drug therapy literature.
Jennifer C, Samp, Glen T, Schumock, A Simon, Pickard   +2 more
openaire   +2 more sources

New Drugs and FDA Publicity

Drug Intelligence & Clinical Pharmacy, 1983
The Food and Drug Administration (FDA) has been criticized for publicly announcing the approval of significant new drugs. This policy was formulated for two reasons: to encourage better public understanding of the benefits and limitations of new drugs and to account to the public for new drug approvals.
openaire   +2 more sources

Publication of Clinical Drug Trials

Annals of Pharmacotherapy, 2001
Clinical drug trials are the best means for establishing the efficacy and safety of drug therapy. Peer-reviewed publications are the most efficient and reliable means for wide dissemination of the results. The investigators and industry have an obligation to publish the data obtained from these trials so that patients may receive the most effective ...
openaire   +2 more sources

Drug Shortages and Public Health

New England Journal of Medicine, 2009
Because the public discussion of drugs is dominated by considerations of their safety, effectiveness, and cost, it is easy to forget that medications have to be manufactured from raw materials before they can be prescribed. The continuing shortages of two medications for enzyme-deficiency disorders and of technetium-99m, the radioactive isotope most ...
openaire   +2 more sources

The Public Interest and Drug Recall

JAMA, 1964
To the Editor:— Many of us in the private practice of medicine were surprised and shocked by the sudden order on Feb 24, 1964, of the Food and Drug Administration recalling tranylcypromine (Parnate) sulfate from public use. The problem raised by this action involves much more than this particular edict. Several questions arise.
openaire   +2 more sources

Publication Trends in the Drug Dependence Literature

The American Journal of Drug and Alcohol Abuse, 1982
Publications dealing with psychotropic drug use and dependence were analyzed for the years 1960-1980 using the numbers of articles cited in each yearly edition of Cumulated Index Medicus. The following headings were reviewed: drug abuse, drug dependence, alcoholism, smoking, heroin addiction, cannabis, cannabinoids, cocaine, phencyclidine, lysergic ...
H, Boxenbaum, J H, Jaffe
openaire   +2 more sources

Drug Abuse, Drug Treatment, and Public Policy

1996
This chapter examines research and ongoing discussion in five areas of drug abuse treatment. In keeping with the theme of this book, we focus on psychological topics and analyses of drug abuse treatment and related policy. We discuss (1) contingency management, (2) skill training, (3) the provision of psychological services in methadone treatment, (4 ...
Sharon M. Hall, H. Westley Clark, Karen Lea Sees   +2 more
openaire   +1 more source

Public drug expenditure in the Republic of Ireland

Expert Review of Pharmacoeconomics & Outcomes Research, 2010
In Ireland, expenditure on medicines in the community has increased over sixfold from 300 million euro in 1998 to 1.9 billion euro in 2008. The Health Service Executive has examined all aspects of the drugs supply chain in an attempt to obtain value for money.
Michael, Barry, Cara, Usher, Lesley, Tilson   +2 more
openaire   +2 more sources

Illegal Drug Use And Public Policy

Health Affairs, 2002
The period from the 1980s to the present has witnessed a lively and unsettled debate concerning the legalization of marijuana, cocaine, heroin, and other illicit substances in the United States. Proponents of legalization argue that the demand for these harmful and potentially addictive substances is not responsive to price. Opponents argue that prices
Michael, Grossman, Frank J, Chaloupka, Kyumin, Shim   +2 more
openaire   +2 more sources

Direct-to the-Public Advertisement of Prescription Drugs

New England Journal of Medicine, 1988
In 1983, Dr. Arthur Hull Hayes, then commissioner of the Food and Drug Administration, discussed direct-to the-public advertisement of prescription medication in a speech to the Pharmaceutical Advertising Council.1 He noted that such direct promotion had first been discussed in 1981, that discussion had been initiated by the drug industry, and that the
openaire   +2 more sources